Allspring Global Investments Holdings, LLC Krystal Biotech, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.3 Billion
- Q4 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 29,777 shares of KRYS stock, worth $4.56 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,777
Previous 111,705
73.34%
Holding current value
$4.56 Million
Previous $20.3 Million
77.04%
% of portfolio
0.01%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding KRYS
# of Institutions
297Shares Held
24.3MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$605 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$441 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$403 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$196 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$135 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.93B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...